adenosine monophosphate has been researched along with cyclosporine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brierley, GP; Gudz, TI; Milgrom, YM; Novgorodov, SA | 1 |
| Belyaeva, EA; Glazunov, VV; Korotkov, SM | 1 |
| Huppelsberg, J; Kahlert, S; Keilhoff, G; Reiser, G; Schild, L | 1 |
| Brun, P; Dubois, J; Dulière, V; Julien, T; Lina, B; Padey, B; Pizzorno, A; Rosa-Calatrava, M; Terrier, O; Traversier, A | 1 |
4 other study(ies) available for adenosine monophosphate and cyclosporine
| Article | Year |
|---|---|
The permeability transition in heart mitochondria is regulated synergistically by ADP and cyclosporin A.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Antimycin A; Calcium; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cattle; Cyclosporine; Drug Synergism; Mitochondria, Heart; Oxygen Consumption; Permeability; Potassium; Swine | 1992 |
Cyclosporin A-sensitive permeability transition pore is involved in Cd(2+)-induced dysfunction of isolated rat liver mitochondria: doubts no more.
Topics: 2,4-Dinitrophenol; Adenosine Diphosphate; Adenosine Monophosphate; Animals; Ascorbic Acid; Cadmium; Cell Respiration; Cyclosporine; Fatty Alcohols; In Vitro Techniques; Intracellular Membranes; Magnesium; Malates; Mitochondria, Liver; Oxygen; Permeability; Potassium Chloride; Rats; Succinic Acid | 2002 |
Brain mitochondria are primed by moderate Ca2+ rise upon hypoxia/reoxygenation for functional breakdown and morphological disintegration.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Animals; Brain; Calcium; Cell Lineage; Cell Membrane; Cyclosporine; Cytochrome c Group; Hypoxia; Hypoxia, Brain; Male; Microscopy, Electron; Mitochondria; NAD; Oxygen Consumption; Rats; Rats, Wistar; Time Factors | 2003 |
In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2.
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Berberine; Betacoronavirus; Chlorocebus aethiops; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cyclosporine; Drug Antagonism; Drug Combinations; Drug Repositioning; Drug Synergism; Humans; Indoles; Lopinavir; Pandemics; Pneumonia, Viral; SARS-CoV-2; Vero Cells | 2020 |